The large population of our focused region consisting of people from different ethnicity, a variety of diseases, rare and genetic diseases which are often seen throughout the region, constitute essential advantages for the research and development (“R&D”) activities of health products. On the other, Turkey is an ideal location for the R&D activities with these particularities in the region. Besides, application for R&D activities is made online before the Turkish Medicines and Medical Devices Agency and concluded without any delay.
Regulations in Turkey that constitute the legal framework of R&D activities for pharmaceuticals, medical devices, and healthcare services are based on the European Union (“EU”) standards. R&D activities could be conducted in fully-fledged health institutions by experienced academicians, and specialist doctors, in conformity with the Good Clinical Practice (“GCP”) standards, with predictable and fewer costs in Turkey, comparing to the EU member countries. In addition to this, the Turkish State provides financial incentives for the R&D activities conducted in Turkey.